Guggenheim says buy this biotech stock

June 18, 2026 4:00 PM

Guggenheim reiterated one biotech name as its top pick Wednesday after the company reported positive monotherapy data for its TL1A ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found